Clear Cell Ovarian Cancer

• CLINICAL_TRIALS research · 2026-02-12
  Clinical Trial Update: A Phase II Randomized, Open Label Non-inferiority Study of NiraParib Maintenance After 3 vs. 6 Cycles of Platinum-based Chemotherapy in completeLy debUlked Advanced HRDpositive High-grade Ovarian Cancer patientS in First Line Therapy [Phase 2]

  This Phase II randomized, open-label trial evaluates whether NiraParib maintenance after 3 cycles of platinum-based chemotherapy is non-infe…

• CLINICAL_TRIALS trial_result · 2022-12-23
  Clinical Trial Update: Testing Whether the Combination of Two Immunotherapy Drugs Have Activity in Recurrent or Persistent Clear Cell Ovarian Cancer [Phase 2]

  This Phase 2 trial evaluated the activity of combining nivolumab and ipilimumab in patients with recurrent or persistent clear cell ovarian …

• CLINICAL_TRIALS trial_result · 2015-12-01
  Clinical Trial Update: Erlotinib Plus Carboplatin and Paclitaxel in Ovarian Carcinoma [Phase 2]

  Phase 2 trial evaluating erlotinib in combination with carboplatin and paclitaxel in ovarian and related cancers. The study has completed an…